Apogee Therapeutics, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APGE and other ETFs, options, and stocks.About APGE
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications.
CEOMichael Henderson
CEOMichael Henderson
Employees196
Employees196
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2022
Founded2022
Employees196
Employees196
APGE Key Statistics
Market cap5.16B
Market cap5.16B
Price-Earnings ratio-17.48
Price-Earnings ratio-17.48
Dividend yield—
Dividend yield—
Average volume692.76K
Average volume692.76K
High today$77.00
High today$77.00
Low today$73.51
Low today$73.51
Open price$73.66
Open price$73.66
Volume986.18K
Volume986.18K
52 Week high$77.00
52 Week high$77.00
52 Week low$26.20
52 Week low$26.20
Stock Snapshot
The current Apogee Therapeutics, Inc.(APGE) stock price is $75.50, with a market capitalization of 5.16B. The stock trades at a price-to-earnings (P/E) ratio of -17.48.
As of 2025-12-05, Apogee Therapeutics, Inc.(APGE) stock has fluctuated between $73.51 and $77.00. The current price stands at $75.50, placing the stock +2.7% above today's low and -1.9% off the high.
Apogee Therapeutics, Inc.(APGE) shares are trading with a volume of 986.18K, against a daily average of 692.76K.
During the past year, Apogee Therapeutics, Inc.(APGE) stock moved between $26.20 at its lowest and $77.00 at its peak.
During the past year, Apogee Therapeutics, Inc.(APGE) stock moved between $26.20 at its lowest and $77.00 at its peak.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own APGE. This list is generated using Robinhood data, and it’s not a recommendation.